ARTICLE DATE: Jul 29, 2021
July 2021
Artificial intelligence (AI) collectively describes computer algorithms that perform tasks which normally require human intelligence. There is immense potential to improve the diagnosis and precision management of skin diseases through AI Interventions (any health intervention which relies upon an AI to serve its purpose). The BAD welcomes adoption of appropriately regulated and governed uses of AI interventions to enhance safe clinical practice and improve patient outcomes. We believe that AI has the potential to improve clinical care, optimise processes and allow greater use of clinical data to inform best practice and outcomes. AI technologies should be developed in areas which clearly address an unmet clinical need; by improving disease management and quality of care and by enhancing patient experience without compromising safety.
The BAD aims to support dermatology departments to ensure that safe, ethical and effective AI interventions are adopted through a robust regulatory framework.
Read more: please find attached the AI statement.
Best Practice London & Women’s Health Professional Care 2025 returns to Olympia London on 26-27 February 2025. This free-to-attend event brings together over 2,000 healthcare professionals working in general practice, primary care, and primary care-f...
Hair loss is a common presentation; it can affect anyone, at any age, and can occur anywhere on the body.
Intensive in-depth three month course to upskill primary care health care professionals in the assessment and management of people with skin conditions.
The October PCDS Skin Club will focus on members who work as Primary Care Professionals (PCPs), our range of members include podiatrists, nurses, ACPs, physician’s associates, pharmacists paramedics and others.
The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes
